| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 6 |
| NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A0A3S5H4W5
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 5 | 9 | PF00656 | 0.476 |
| CLV_PCSK_SKI1_1 | 16 | 20 | PF00082 | 0.568 |
| DEG_SCF_FBW7_1 | 163 | 170 | PF00400 | 0.691 |
| DOC_CKS1_1 | 140 | 145 | PF01111 | 0.665 |
| DOC_CKS1_1 | 164 | 169 | PF01111 | 0.694 |
| DOC_CYCLIN_yClb3_PxF_3 | 163 | 169 | PF00134 | 0.623 |
| DOC_MAPK_gen_1 | 124 | 134 | PF00069 | 0.621 |
| DOC_PP1_RVXF_1 | 14 | 20 | PF00149 | 0.550 |
| DOC_PP4_FxxP_1 | 19 | 22 | PF00568 | 0.523 |
| DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.595 |
| DOC_USP7_MATH_1 | 196 | 200 | PF00917 | 0.627 |
| DOC_USP7_MATH_1 | 40 | 44 | PF00917 | 0.743 |
| DOC_USP7_MATH_1 | 77 | 81 | PF00917 | 0.608 |
| DOC_WW_Pin1_4 | 139 | 144 | PF00397 | 0.698 |
| DOC_WW_Pin1_4 | 159 | 164 | PF00397 | 0.617 |
| DOC_WW_Pin1_4 | 167 | 172 | PF00397 | 0.685 |
| DOC_WW_Pin1_4 | 209 | 214 | PF00397 | 0.646 |
| DOC_WW_Pin1_4 | 221 | 226 | PF00397 | 0.696 |
| DOC_WW_Pin1_4 | 233 | 238 | PF00397 | 0.581 |
| DOC_WW_Pin1_4 | 273 | 278 | PF00397 | 0.650 |
| DOC_WW_Pin1_4 | 63 | 68 | PF00397 | 0.629 |
| LIG_14-3-3_CanoR_1 | 127 | 132 | PF00244 | 0.712 |
| LIG_14-3-3_CanoR_1 | 16 | 22 | PF00244 | 0.558 |
| LIG_14-3-3_CanoR_1 | 291 | 300 | PF00244 | 0.606 |
| LIG_14-3-3_CanoR_1 | 50 | 55 | PF00244 | 0.579 |
| LIG_14-3-3_CanoR_1 | 83 | 91 | PF00244 | 0.626 |
| LIG_14-3-3_CanoR_1 | 93 | 102 | PF00244 | 0.476 |
| LIG_BRCT_BRCA1_1 | 293 | 297 | PF00533 | 0.603 |
| LIG_FHA_2 | 186 | 192 | PF00498 | 0.586 |
| LIG_FHA_2 | 22 | 28 | PF00498 | 0.643 |
| LIG_LIR_Gen_1 | 181 | 192 | PF02991 | 0.599 |
| LIG_LIR_Gen_1 | 294 | 300 | PF02991 | 0.595 |
| LIG_LIR_Gen_1 | 45 | 54 | PF02991 | 0.602 |
| LIG_LIR_Gen_1 | 8 | 18 | PF02991 | 0.454 |
| LIG_LIR_LC3C_4 | 12 | 15 | PF02991 | 0.443 |
| LIG_LIR_Nem_3 | 181 | 187 | PF02991 | 0.608 |
| LIG_LIR_Nem_3 | 217 | 223 | PF02991 | 0.589 |
| LIG_LIR_Nem_3 | 294 | 300 | PF02991 | 0.595 |
| LIG_LIR_Nem_3 | 45 | 51 | PF02991 | 0.600 |
| LIG_LIR_Nem_3 | 8 | 13 | PF02991 | 0.449 |
| LIG_PDZ_Class_3 | 295 | 300 | PF00595 | 0.663 |
| LIG_SH2_CRK | 204 | 208 | PF00017 | 0.647 |
| LIG_SH3_3 | 161 | 167 | PF00018 | 0.681 |
| LIG_SUMO_SIM_par_1 | 129 | 136 | PF11976 | 0.632 |
| LIG_TRAF2_1 | 188 | 191 | PF00917 | 0.596 |
| MOD_CDK_SPK_2 | 139 | 144 | PF00069 | 0.668 |
| MOD_CDK_SPxK_1 | 233 | 239 | PF00069 | 0.655 |
| MOD_CK1_1 | 126 | 132 | PF00069 | 0.588 |
| MOD_CK1_1 | 133 | 139 | PF00069 | 0.602 |
| MOD_CK1_1 | 157 | 163 | PF00069 | 0.746 |
| MOD_CK1_1 | 232 | 238 | PF00069 | 0.710 |
| MOD_CK1_1 | 246 | 252 | PF00069 | 0.811 |
| MOD_CK1_1 | 289 | 295 | PF00069 | 0.622 |
| MOD_CK1_1 | 42 | 48 | PF00069 | 0.596 |
| MOD_CK1_1 | 92 | 98 | PF00069 | 0.579 |
| MOD_CK2_1 | 185 | 191 | PF00069 | 0.664 |
| MOD_CK2_1 | 28 | 34 | PF00069 | 0.646 |
| MOD_CK2_1 | 290 | 296 | PF00069 | 0.699 |
| MOD_GlcNHglycan | 144 | 147 | PF01048 | 0.685 |
| MOD_GlcNHglycan | 156 | 159 | PF01048 | 0.755 |
| MOD_GlcNHglycan | 198 | 201 | PF01048 | 0.614 |
| MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.780 |
| MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.583 |
| MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.604 |
| MOD_GlcNHglycan | 95 | 98 | PF01048 | 0.618 |
| MOD_GSK3_1 | 123 | 130 | PF00069 | 0.625 |
| MOD_GSK3_1 | 138 | 145 | PF00069 | 0.600 |
| MOD_GSK3_1 | 159 | 166 | PF00069 | 0.699 |
| MOD_GSK3_1 | 17 | 24 | PF00069 | 0.630 |
| MOD_GSK3_1 | 172 | 179 | PF00069 | 0.636 |
| MOD_GSK3_1 | 229 | 236 | PF00069 | 0.664 |
| MOD_GSK3_1 | 243 | 250 | PF00069 | 0.709 |
| MOD_GSK3_1 | 275 | 282 | PF00069 | 0.632 |
| MOD_GSK3_1 | 286 | 293 | PF00069 | 0.616 |
| MOD_GSK3_1 | 42 | 49 | PF00069 | 0.581 |
| MOD_GSK3_1 | 77 | 84 | PF00069 | 0.792 |
| MOD_GSK3_1 | 85 | 92 | PF00069 | 0.525 |
| MOD_N-GLC_1 | 138 | 143 | PF02516 | 0.669 |
| MOD_N-GLC_1 | 232 | 237 | PF02516 | 0.612 |
| MOD_N-GLC_1 | 279 | 284 | PF02516 | 0.656 |
| MOD_N-GLC_1 | 40 | 45 | PF02516 | 0.651 |
| MOD_NEK2_1 | 154 | 159 | PF00069 | 0.624 |
| MOD_NEK2_1 | 177 | 182 | PF00069 | 0.664 |
| MOD_NEK2_1 | 244 | 249 | PF00069 | 0.629 |
| MOD_NEK2_1 | 265 | 270 | PF00069 | 0.702 |
| MOD_NEK2_1 | 68 | 73 | PF00069 | 0.596 |
| MOD_PIKK_1 | 157 | 163 | PF00454 | 0.686 |
| MOD_PIKK_1 | 275 | 281 | PF00454 | 0.671 |
| MOD_PIKK_1 | 286 | 292 | PF00454 | 0.618 |
| MOD_PIKK_1 | 42 | 48 | PF00454 | 0.571 |
| MOD_PK_1 | 127 | 133 | PF00069 | 0.620 |
| MOD_PKA_2 | 123 | 129 | PF00069 | 0.670 |
| MOD_PKA_2 | 286 | 292 | PF00069 | 0.616 |
| MOD_PKA_2 | 82 | 88 | PF00069 | 0.659 |
| MOD_PKA_2 | 92 | 98 | PF00069 | 0.499 |
| MOD_Plk_4 | 127 | 133 | PF00069 | 0.592 |
| MOD_Plk_4 | 180 | 186 | PF00069 | 0.617 |
| MOD_ProDKin_1 | 139 | 145 | PF00069 | 0.696 |
| MOD_ProDKin_1 | 159 | 165 | PF00069 | 0.621 |
| MOD_ProDKin_1 | 167 | 173 | PF00069 | 0.678 |
| MOD_ProDKin_1 | 209 | 215 | PF00069 | 0.647 |
| MOD_ProDKin_1 | 221 | 227 | PF00069 | 0.695 |
| MOD_ProDKin_1 | 233 | 239 | PF00069 | 0.581 |
| MOD_ProDKin_1 | 273 | 279 | PF00069 | 0.653 |
| MOD_ProDKin_1 | 63 | 69 | PF00069 | 0.632 |
| TRG_DiLeu_BaLyEn_6 | 149 | 154 | PF01217 | 0.542 |
| TRG_ENDOCYTIC_2 | 204 | 207 | PF00928 | 0.647 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1I318 | Leptomonas seymouri | 43% | 93% |
| A4H385 | Leishmania braziliensis | 70% | 92% |
| A4HRJ0 | Leishmania infantum | 99% | 100% |
| E9AC58 | Leishmania major | 90% | 100% |
| E9AJF4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 96% |